Scopolamine as an antidepressant: a systematic review.
Jaffe Robert J, Novakovic Vladan, Peselow Eric D·Clinical neuropharmacology
OBJECTIVES: The cholinergic-adrenergic hypothesis of mania and depression states that depression is characterized by an increase in central cholinergic activity relative to noradrenergic tone. Scopolamine is a centrally acting competitive inhibitor of the muscarinic cholinergic receptor site. This review seeks to find…